The Recall Desk

Manufacturer

Teva Pharmaceuticals USA, Inc.

83 recalls in our database name Teva Pharmaceuticals USA, Inc. as the manufacturing or recalling firm.

What the numbers show

Total
83
Critical
0
Severe
8
Most recent
2026-05-13

Of the 83 recalls from Teva Pharmaceuticals USA, Inc. we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 8 (10%) are Severe.

About this listing

The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.

Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.

76–83 of 83

  • ModerateFDA (Drugs)·D-237-2013·2013-04-10

    Teva Recalls Clonazepam Tablets Due to Content Uniformity Failure

    Teva Pharmaceuticals is recalling specific lots of Clonazepam orally disintegrating tablets because they failed content uniformity specifications.

    Product
    CLONAZEPAM ORALLY DISINTERGRATING Tablets, USP, 0.5 mg, 60 tablets (10 blister cards of 6 tablets each), TEVA PHARMACEUTICALS USA, Sellersville PA 18960, NDC #0555-0096-96
    Category
    Drug
    Distribution
    1 state
  • ModerateFDA (Drugs)·D-193-2013·2013-03-20

    Teva Recalls Terazosin Hydrochloride Capsules Due to Foreign Capsule Presence

    Teva Pharmaceuticals USA is recalling specific lots of Terazosin Hydrochloride Capsules because a foreign capsule was found in one bottle.

    Product
    Terazosin Hydrochloride Capsules, 2 mg, packaged in a) 100-count bottles (NDC 0093-4337-01); and b) 1000-count bottles (NDC 0093-4337-10), Rx only, Manufactured in India By: Intas Pharmaceuticals Ltd., Ahmedabad, Gujarat, India - 382 210; Manufactured For: Teva Pharmaceuticals US
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-128-2013·2013-01-23

    Teva Recalls Cabergoline Tablets Due to Impurity Specification Failure

    Teva Pharmaceuticals is recalling 13,232 bottles of Cabergoline 0.5 mg tablets because the product may not meet impurity specifications over its shelf life.

    Product
    CABERGOLINE — CABERGOLINE (CABERGOLINE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-1442-2012·2012-08-15

    Teva Recalls Copaxone Injections Due to Foreign Particle Presence

    Teva Pharmaceuticals is recalling specific lots of Copaxone (glatiramer acetate) injection due to the presence of a foreign particle identified from a customer complaint.

    Product
    COPAXONE — COPAXONE (GLATIRAMER ACETATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-1409-2012·2012-07-11

    Teva Recalls Metoprolol Tartrate Tablets Due to Weight Variations

    Teva Pharmaceuticals is recalling 2,268 bottles of Metoprolol Tartrate 50 mg tablets in Ohio because some tablets may not meet weight specifications.

    Product
    Metoprolol Tartrate Tablets USP 50 mg, 1000 count bottle, Rx only, Manufactured in india By: Emcure Pharmaceuticals LTD. Hinjwadi, Pune, India, Manufactured for TEVA Phamaceuticals USA, Sellersville, PA 18960, NDC 0093-0733-10
    Category
    Drug
    Distribution
    1 state
  • ModerateFDA (Drugs)·D-1397-2012·2012-07-04

    Teva Recalls Zeosa Oral Contraceptive Tablets Due to Impurity Concerns

    Teva Pharmaceuticals is recalling specific lots of Zeosa chewable oral contraceptive tablets because they may not meet impurity specifications.

    Product
    Zeosa (norethindrone and ethinyl estradiol tablets USP, (chewable), 0.4 mg/0.035 mg, and ferrous fumarate tablets USP, (chewable) 75 mg), 3 Blister Cards, 28 Tablets Each, Rx only, TEVA Pharmaceuticals USA, Sellersville, PA 18960, NDC 0093-2090-28 and 0093-2090-58, cartons contai
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-1396-2012·2012-07-04

    Teva Recalls Mefloquine Hydrochloride Tablets Due to Weight Variations

    Teva Pharmaceuticals is recalling Mefloquine Hydrochloride 250 mg tablets because they may be underweight or overweight.

    Product
    MEFLOQUINE HYDROCHLORIDE — MEFLOQUINE HYDROCHLORIDE (MEFLOQUINE HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide

About this company

Community-sourced company facts from Wikidata, not from any recall agency. This is background on the corporate entity — it says nothing about the recall(s) listed on this page, which come from the agency source notice above.

Teva Pharmaceuticals CR

company in Prague, Czechia

Country
Czech Republic
Founded
1997

Official website

Source: Wikidata (Q41567143), licensed CC0. Wikidata is community-edited and may not reflect the current corporate structure.